Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Smurf1em1flox/Cya
Common Name:
Smurf1-flox
Product ID:
S-CKO-16342
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Smurf1-flox
Strain ID
CKOCMP-75788-Smurf1-B6J-VA
Gene Name
Smurf1
Product ID
S-CKO-16342
Gene Alias
4930431E10Rik; mKIAA1625
Background
C57BL/6JCya
NCBI ID
75788
Modification
Conditional knockout
Chromosome
5
Phenotype
MGI:1923038
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Smurf1em1flox/Cya mice (Catalog S-CKO-16342) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000085684
NCBI RefSeq
NM_001038627
Target Region
Exon 2~3
Size of Effective Region
~2.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Smurf1, also known as SMAD specific E3 ubiquitin protein ligase 1, is a HECT-type E3 ubiquitin ligase. It plays crucial roles in multiple biological pathways, such as the bone morphogenetic protein pathway, non-canonical Wnt pathway, and mitogen-activated protein kinase pathway [7]. It is involved in cell growth, morphogenesis, migration, polarity, and autophagy, and is related to physiological manifestations like age-dependent bone formation deficiency and tumor cell invasion [7]. Genetic models, like Smurf1-knockout mice, have been valuable in studying its functions.

In cancer, overexpression of Smurf1 is linked to poor prognosis in various cancers. For example, in glioblastoma, colon cancer, and clear cell renal cell carcinoma, it acts as a tumor promoter by ubiquitinating and degrading tumor-suppressing proteins [1]. In KRAS-mutated colorectal cancer, Smurf1-mediated PDK1 neddylation is essential for PI3K-Akt signaling and tumorigenesis, and Smurf1 deficiency reduces tumorigenesis in a genetic mouse model [3]. In hepatocellular carcinoma, Smurf1-mediated ubiquitination of UVRAG promotes autophagosome maturation and inhibits tumor growth [2]. In glioblastoma, ER stress induces Smurf1 degradation, and knockdown of Smurf1 leads to cell apoptosis, while overexpression activates NRF2 signaling to protect cells from ER-stress-induced death [4].

In lupus nephritis, SMURF1 upregulation activates the cGAS/STING/IFN-1 signal axis by ubiquitinating YY1, facilitating apoptosis in podocytes, and SMURF1 knockdown inhibits disease progression in vivo [6]. In dry age-related macular degeneration, inhibiting Smurf1 alleviates acute retina injury, and Smurf1 is involved in exacerbating oxidative stress injury and inflammation in the retina [8]. In ameloblasts, Smurf1 regulates cell polarization through ubiquitination-mediated degradation of RhoA, and local knockdown in rat lower incisor ameloblasts results in enamel matrix secretion disorder [5].

In conclusion, Smurf1 is a key regulator in multiple biological processes and disease conditions. Model-based research, especially using Smurf1 KO/CKO mouse models, has revealed its significance in cancer, lupus nephritis, age-related macular degeneration, and tooth development. Understanding Smurf1 provides insights into disease mechanisms and potential therapeutic targets.

References:
1. Xia, Qin, Li, Yang, Han, Da, Dong, Lei. 2020. SMURF1, a promoter of tumor cell progression? In Cancer gene therapy, 28, 551-565. doi:10.1038/s41417-020-00255-8. https://pubmed.ncbi.nlm.nih.gov/33204002/
2. Feng, Xing, Jia, Yanyan, Zhang, Yuyu, Qiu, Xingfeng, Zhang, Zhiyong. 2019. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth. In Autophagy, 15, 1130-1149. doi:10.1080/15548627.2019.1570063. https://pubmed.ncbi.nlm.nih.gov/30686098/
3. Peng, Zhiqiang, Fang, Wei, Wu, Bo, Cui, Chun-Ping, Zhang, Lingqiang. 2024. Targeting Smurf1 to block PDK1-Akt signaling in KRAS-mutated colorectal cancer. In Nature chemical biology, 21, 59-70. doi:10.1038/s41589-024-01683-5. https://pubmed.ncbi.nlm.nih.gov/39039255/
4. Dong, Lei, Xu, Mengchuan, Li, Yang, Zhou, Liying, Xia, Qin. 2023. SMURF1 attenuates endoplasmic reticulum stress by promoting the degradation of KEAP1 to activate NRF2 antioxidant pathway. In Cell death & disease, 14, 361. doi:10.1038/s41419-023-05873-2. https://pubmed.ncbi.nlm.nih.gov/37316499/
5. Niu, Haoman, Bi, Fei, Zhao, Wenjun, Guo, Weihua, Chen, Yu. 2022. Smurf1 regulates ameloblast polarization by ubiquitination-mediated degradation of RhoA. In Cell proliferation, 56, e13387. doi:10.1111/cpr.13387. https://pubmed.ncbi.nlm.nih.gov/36579844/
6. Li, Xiaoyan, Tao, Sisi, Xu, Zhiquan, Xiang, Wei, He, Xiaojie. 2023. SMURF1 activates the cGAS/STING/IFN-1 signal axis by mediating YY1 ubiquitination to accelerate the progression of lupus nephritis. In Autoimmunity, 56, 2281235. doi:10.1080/08916934.2023.2281235. https://pubmed.ncbi.nlm.nih.gov/37994046/
7. Cao, Yu, Zhang, Lingqiang. 2012. A Smurf1 tale: function and regulation of an ubiquitin ligase in multiple cellular networks. In Cellular and molecular life sciences : CMLS, 70, 2305-17. doi:10.1007/s00018-012-1170-7. https://pubmed.ncbi.nlm.nih.gov/23007848/
8. Li, Duo, Wei, Ting-Ting, Cai, Jiping, Yao, Yong, Zhu, Lingpeng. 2023. Smurf1: A possible therapeutic target in dry age-related macular degeneration. In Experimental eye research, 233, 109549. doi:10.1016/j.exer.2023.109549. https://pubmed.ncbi.nlm.nih.gov/37348673/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest